Archives: Speakers

Dr Clemens Busse is currently working as a Senior Client Manager, Medical Devices at BSI, covering EMEA. He has worked in the IVD industry since 2009 in responsible functions for design and development and quality control.

His tasks involved research activities, project planning and budgeting, development planning, data evaluation, raw material validation, performance and stability studies, and product troubleshooting. The product range he was responsible for during his career covers manual assays to fully automated solutions.

He obtained an engineering degree in Biotechnology, followed by a PHD from the German Cancer Research Center in Heidelberg, Germany, in molecular virology.

Edo Madussi is the Managing Director, of Euromed Pharma US and Business Unit head of the Clinical Trial Division at the Petrone Group.

His business experience combined with his academic background and four spoken languages – English, German, French, and Italian – brought him to develop an extensive network within the global clinical supply chain space.  He is currently developing one of the latest ventures of the Petrone Group: a US-based integrated platform to support Clinical Trial Sponsors and other industry players around the world with a wide range of services in the R&D space.

Dr. Graham Wood is a leader in the conduct and design of clinical pharmacology studies having held senior executive roles in a number of the top clinical research sites in the world.

In total, he has over 22 years of experience and has been involved with more than 200 first-in-human studies as well as over 2,000 studies across all areas of clinical pharmacology.

After finishing his PhD in Neurology and Neurosurgery, Graham worked at MDS Pharma Services, Cetero Research, Manna Research and Altasciences as well as spending two years working at biotechnology companies.

Johanna Morand is the Associate Director, Site Contracts, at Premier Research, responsible for EMEA, LATAM, and APAC, along with the Benelux Country Lead. She has 12 years of experience negotiating contracts for clinical trials (previously with Genzyme, a Sanofi Company, Parexel, and Cmed). Ms. Morand leads an international team of Contract Leads and Contract Specialists. Her aim remains to balance timely execution while managing legal, financial, and operational risks. Ms. Morand holds an LLM in European Law from Leiden University and an LLM in Law and Economics from Utrecht University where she wrote a thesis on European Orphan Medicinal Product Regulations.

Dr. Mahillo has 28+ years of experience in the clinical research arena, 25 of them in oncology global trials. Her areas of expertise are inmuno-oncology, including cancer vaccines, advanced therapies, genetically modified organisms and other immuno therapies. She has an in-depth knowledge on oncology networks and advocacy groups, with which she cooperates since 1999. Dr. Mahillo is a professor/magister in several Master programs administered at different Universities (Universidad Alcalá de Henares, Universidad CEU San Pablo, CESIF). She has authored of 3 books, 20 scientific articles, and 24 contributions to scientific congresses. Dr. Mahillo was awarded the first prize of the Spanish Society of Medical Oncology (SEOM) in 2015 for her project “Y Seguiré” (will keep on moving), for the promotion of clinical research. Dr. Mahillo obtained her PhD with a research on the role of multicatalytic proteinase (proteasome) as an oncology intracellular target, research line that ended up with the development of bortezomib, a proteasome inhibitor approved for the treatment of multiple myeloma patients.